PetIQ, Inc. (PETQ)
USD 30.98
(-0.03%)
USD 30.98
(-0.03%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 159.3 Million USD | 11.71% |
| 2022 | 142.6 Million USD | 47.87% |
| 2021 | 96.44 Million USD | -1.36% |
| 2020 | 97.77 Million USD | 22.67% |
| 2019 | 79.7 Million USD | -13.5% |
| 2018 | 92.14 Million USD | 109.15% |
| 2017 | 44.05 Million USD | 28.7% |
| 2016 | 34.23 Million USD | 1.62% |
| 2015 | 33.68 Million USD | 44.34% |
| 2014 | 23.33 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 164.96 Million USD | -23.41% |
| 2024 Q1 | 215.38 Million USD | 35.2% |
| 2023 Q4 | 159.3 Million USD | 24.34% |
| 2023 Q1 | 158.08 Million USD | 10.86% |
| 2023 Q2 | 141.64 Million USD | -10.4% |
| 2023 Q3 | 128.12 Million USD | -9.55% |
| 2023 FY | 159.3 Million USD | 11.71% |
| 2022 Q4 | 142.6 Million USD | -3.02% |
| 2022 FY | 142.6 Million USD | 47.87% |
| 2022 Q1 | 167.71 Million USD | 73.91% |
| 2022 Q2 | 160.06 Million USD | -4.56% |
| 2022 Q3 | 147.04 Million USD | -8.13% |
| 2021 FY | 96.44 Million USD | -1.36% |
| 2021 Q3 | 108.14 Million USD | -8.65% |
| 2021 Q4 | 96.44 Million USD | -10.82% |
| 2021 Q2 | 118.38 Million USD | -9.3% |
| 2021 Q1 | 130.52 Million USD | 33.5% |
| 2020 Q1 | 118.73 Million USD | 48.98% |
| 2020 Q4 | 97.77 Million USD | 16.56% |
| 2020 Q3 | 83.88 Million USD | -24.64% |
| 2020 Q2 | 111.3 Million USD | -6.26% |
| 2020 FY | 97.77 Million USD | 22.67% |
| 2019 Q4 | 79.7 Million USD | -18.64% |
| 2019 FY | 79.7 Million USD | -13.5% |
| 2019 Q1 | 112.53 Million USD | 22.14% |
| 2019 Q2 | 98.43 Million USD | -12.53% |
| 2019 Q3 | 97.96 Million USD | -0.47% |
| 2018 Q4 | 92.14 Million USD | 20.33% |
| 2018 FY | 92.14 Million USD | 109.15% |
| 2018 Q1 | 79.23 Million USD | 79.86% |
| 2018 Q2 | 81.2 Million USD | 2.48% |
| 2018 Q3 | 76.57 Million USD | -5.7% |
| 2017 Q3 | 34.65 Million USD | -19.04% |
| 2017 Q2 | 42.8 Million USD | -10.92% |
| 2017 Q1 | 48.05 Million USD | 40.38% |
| 2017 FY | 44.05 Million USD | 28.7% |
| 2017 Q4 | 44.05 Million USD | 27.13% |
| 2016 FY | 34.23 Million USD | 1.62% |
| 2016 Q4 | 34.23 Million USD | 0.0% |
| 2016 Q1 | 39.13 Million USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 33.68 Million USD | 44.34% |
| 2014 FY | 23.33 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | -3226.523% |
| Safety Shot Inc | 1.86 Million USD | -8420.806% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | -4.74% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | -43.269% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -2253.509% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -392.729% |
| Dynavax Technologies Corporation | 53.29 Million USD | -198.947% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -142.764% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -1267.811% |
| Pacira BioSciences, Inc. | 104.35 Million USD | -52.664% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -2677.957% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -2677.957% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -19573.68% |
| Journey Medical Corporation | 10.2 Million USD | -1460.935% |
| Alpha Teknova, Inc. | 11.59 Million USD | -1274.064% |
| Procaps Group, S.A. | 96.83 Million USD | -64.519% |
| Theratechnologies Inc. | 6.06 Million USD | -2526.261% |
| Harrow Health, Inc. | 10.86 Million USD | -1365.989% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -5759.103% |
| Biofrontera Inc. | 10.9 Million USD | -1360.479% |
| DURECT Corporation | 2.21 Million USD | -7079.315% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -105.804% |
| Cronos Group Inc. | 30.33 Million USD | -425.097% |
| OptiNose, Inc. | 8.05 Million USD | -1878.502% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -15930899900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -2695.369% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -463.866% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -5850.778% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -3356.205% |
| Radius Health, Inc. | 278.64 Million USD | 42.827% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -4665.071% |
| ProPhase Labs, Inc. | 3.84 Million USD | -4047.592% |
| Phibro Animal Health Corporation | 265.91 Million USD | 40.089% |
| Procaps Group S.A. | 96.83 Million USD | -64.519% |
| Alvotech | 74.43 Million USD | -114.03% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 95.409% |
| Rockwell Medical, Inc. | 5.87 Million USD | -2613.49% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -1161.054% |
| SIGA Technologies, Inc. | 64.21 Million USD | -148.074% |
| Tilray Brands, Inc. | 252.08 Million USD | 36.804% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -298.482% |
| Shineco, Inc. | 1.58 Million USD | -9928.737% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 104374.83% |
| Incannex Healthcare Limited | -10.01 Million USD | 1690.704% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -315.95% |
| Alimera Sciences, Inc. | 1.87 Million USD | -8378.393% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -322.727% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -9792.566% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -3453.625% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -62533.28% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -1434.769% |
| Hempacco Co., Inc. | 2.54 Million USD | -6165.525% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | -114.03% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -233.324% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -148.808% |
| Currenc Group, Inc. | 732.91 Thousand USD | -21636.473% |
| Kamada Ltd. | 87.74 Million USD | -81.555% |
| Indivior PLC | 141.79 Million USD | -12.348% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -32962.635% |
| Flora Growth Corp. | 8.5 Million USD | -1772.461% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -62533.28% |
| Evolus, Inc. | 10.99 Million USD | -1348.527% |
| HUTCHMED (China) Limited | 50.25 Million USD | -216.982% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -50.529% |
| Akanda Corp. | 1.28 Million USD | -12279.341% |